XML 43 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transactions (Tables)
6 Months Ended
Jun. 30, 2014
Related Party Transactions [Abstract]  
Summary of activities related to related party

Milestones Payments 
     
(1) filing of an New Drug Application (“NDA”) or regulatory approval for each licensed product $750,000 
(2) upon the receipt of regulatory approval from the U.S. FDA for each licensed product  1,750,000